Has your child been affected by neuroblastoma? Call 020 7284 0800 for help and information.

Latest News

Joint statement in response to NICE’s preliminary decision on Anti-GD2 antibody therapy dinutuximab beta for NHS clinical use.

From Solving Kids’ Cancer, Neuroblastoma UK, the Children’s Cancer and Leukaemia group, JACK, The Bradley Lowery Foundation, Hugs from Henry, Christopher’s Smile, Niamh’s Next Steps and Smile with Siddy. Charities and Clinicians that support children with high-risk neuroblastoma and their families have joined together in response to the decision not to recommend a life-saving drug

Read story

Urgent appeal launched to help Kira Noble

Help us raise £340,000 by 10th May for 14-year-old Kira Noble’s life-saving cancer treatment in New York. Kira has been fighting neuroblastoma since she was just 11, and has endured years of gruelling treatment to try to get rid of her disease. Sadly, despite best medical efforts it was not possible to remove a growing

Read story

Generosity of an anonymous donor benefits children with cancer

Thanks to an anonymous and generous donor, children’s cancer charities including Solving Kids’ Cancer have benefited from the sale of a valuable sculpture. Called ‘The Boy with the Dolphin’ by David Wynne it was auctioned recently at Christie’s for an amazing £80,000! The money will be split between our charity and other great causes Abbie’s

Read story

Solving Kids’ Cancer wins charity of the month poll

Exciting news! We are delighted to announce that we won the My Favourite Voucher Codes March charity of the month poll. We’d like to say a HUGE thank you to everyone who kindly voted for us.  Your support will help us continue making a difference for children with neuroblastoma and their families, through funding ground-breaking

Read story

Anti-GD2 Antibody Therapy Update, March 2018

A NICE committee hearing will be held on 11th April to discuss whether or not to recommend dinutuximab beta antibody therapy for NHS use. An application has been received from pharmaceutical company EUSA Pharma (who hold the European and UK licence). As we know, dinutuximab beta is an essential treatment that offers hope in the

Read story

New partnership to help families travelling abroad for treatment

Many families travel abroad so that their child can have treatment to help them fight neuroblastoma. Visiting another country can seem overwhelming, so we help families prepare for this – from liaising with medical professionals to arranging flight tickets and accommodation. We’re delighted to let you know that we’re now working with the St George’s

Read story

Urgent! New law means we need your consent to stay in touch

Say Yes to keep in touch here We know you care about our work for children and families affected by neuroblastoma. But when a new law comes into place on 25th May 2018, we won’t be able to keep in contact with you by email or telephone unless you’ve told us that it’s OK. Even

Read story

Support Solving Kids’ Cancer this March without spending a penny!

Throughout March, you can support children battling neuroblastoma by voting for us to be Charity of the Month for My Favourite Voucher Codes. How does it work? MFVC allows you to save money on your shopping with thousands of voucher codes from all your favourite retailers, restaurants and hotels. As if that wasn’t incentive enough,

Read story

Have your say on our brand!

We’ve been thinking about how we look and talk about our work and want to hear your views. Our survey takes 10 minutes to complete and if you do, you could win £50 to spend in Marks and Spencer*. Take part in our brand survey Anecdotally, and often second-hand, we hear different opinions about our

Read story

SKC Appoint Scientific Advisory Board of International Repute

We are delighted to announce that we have appointed a Scientific Advisory Board (SAB) of international repute, concentrating specifically on developing a Research Strategy for Solving Kids’ Cancer and to oversee the development of a formal, structured and accredited research funding award process. Professor Andy Pearson, Dr John Maris, Dr Juliet Gray and Dr Lucas

Read story

Join our newsletter

Privacy Policy (click to expand)

Follow Us

Useful links

Contact us

Solving Kids' Cancer

Tel: 020 7284 0800

CAN Mezzanine
49-51 East Road
London
N1 6AH

Contact us

Share This